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Editorial on the Research Topic
Genomic Basis of Antibiotic Resistance and Virulence in Acinetobacter
Genome sequencing has drastically changed our understanding of the biology of many bacteria. In
this respect, species from the genus Acinetobacter are no exception. The main goal of this Research
Topic was to broaden the knowledge about antibiotic resistance and virulence for Acinetobacter
species from a genomic point of view. This Research Topic encompasses articles adding to the
biology of the genus Acinetobacter in three major themes: Mobiles Genetic Elements (MGE),
Antibiotic Resistance, and Epidemiology and Pathogenesis.
MGEs are one of the hallmarks of the accessory genome in many bacterial species. Furthermore,
they are key elements for Horizontal Gene Transfer (HGT) and known spreaders of antibiotic
resistance genes (ARGs). In their contribution Leal et al. analyzed 46 Acinetobacter spp. isolates
(all but one A. baumannii) from 5 hospitals in Recife, Brazil. They showed that different lineages
defined by multilocus sequence typing (MLST) sequence types (STs) are spreading in hospitals in
Recife. Notably, ARGs were clearly associated with different MGEs. The authors concluded that
polyclonal dissemination is peppered with exchange ofMGEs containing ARGs.MGEs can also be a
source of genome rearrangements; in this regard, Castro-Jamies et al. showed that this is the case for
the understudiedA. haemolyticus. Analyzing 47 genomes (including 30Mexican isolates sequenced
by them), they demonstrated that this species has an open pangenome and that hypervariable
regions have an array of diverse MGEs. Notably, even isolates belonging to the same clade can
have large differences in gene content. Thus, it is fair to say that A. haemolyticus has a very dynamic
genome. Plasmids are one of the most well-known mechanisms for disseminating ARGs. To gain a
better understanding of plasmid evolution in A. baumannii, Salgado-Camargo et al. conducted an
in silico analysis of 173 A. baumannii plasmids covering 47 STs and 17 countries. They found that
some plasmids might have the capacity to replicate in other bacterial genera, while other groups of
plasmids seem to be confined to the genus Acinetobacter. Moreover, some plasmids are extensively
distributed in the species, notwithstanding the apparent absence of the mobilization mechanisms.
They also noted that around 35% of the plasmids have ARGs and that transposons are important
elements concerning gene flow between plasmids. For their part, Mindlin et al. characterized 44
plasmids from 5 permafrost A. lwoffii isolates to understand the diversity of plasmids in this
Acinetobacter species. They found that a small number of plasmids are distributed in clinical
settings and the environment. Remarkably, plasmids from the permafrost isolates are closely related
to plasmids from clinical isolates and some of them carry ARGs in the accessory region. The authors
inferred that clinical plasmids originated from the plasmids present in the permafrost. The icing on
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the cake is the study by Ghaly et al. They studied 21
multidrug resistance mega-plasmids (present in 11 Acinetobacter
spp.) sampled from diverse locales across the world. They
demonstrated that plasmids sampled within the same region
are often distantly related in terms of the core-genome;
however, they are much more similar concerning the accessory
genome. Importantly, they also determined that plasmids
from different geographic areas are enriched in region-
specific functional capacities. Importantly, these plasmids encode
221 ARGs conferring resistance against 13 drug classes.
The authors concluded that mega-plasmids are spreaders of
ARGs. Collectively, the above studies clearly show that MGEs
in Acinetobacter have a very important role in spreading
multidrug resistance phenotypes. Beyond that, these and others
studies suggest that MGEs in Acinetobacter species significantly
contribute to the acquisitions of genes required for functions
under different living conditions.
Acinetobacter baumannii displays an impressive capability
to resist the action of antibiotics. It uses a combination of
intrinsic and acquired mechanisms to gain antibiotic resistance.
In this issue half a dozen manuscripts describe some of these
resistance mechanisms. Efflux of antibiotics, mediated by RND
efflux pumps, is an important means of intrinsic resistance
in Gram-negative bacteria. Antibiotic resistant A. baumannii
isolates are reported globally and this is highlighted in the
collection of manuscripts in this issue. Roy et al. describe a 7-
year study from India where antibiotic resistance mechanisms
were evaluated in neonatal septicaemia A. baumannii isolates.
Worryingly, they found more than 90% of the isolates were
resistant to fluoroquinolones (FQ). This resistance was associated
primarily with mutations in the target genes, as more than
90% of the FQ resistant isolates carried mutations in gyrA
and parC. They found widespread overexpression of efflux
pumps, in particular that of AdeABC. This concerning finding
highlights the prevalence of FQ resistance in A. baumannii and
also underscores the fact that multiple resistance mechanisms
in combination contribute to the reduced susceptibility of
A. baumannii. Three additional manuscripts describe mobile
resistance elements in A. baumannii. These studies come from
three different continents highlighting the global spread of A.
baumannii. Cerezales et al. studied the mobile genetic elements
in three multidrug resistant (MDR) isolates of A. baumannii
from Bolivia. Large and diverse numbers of transposons,
plasmids and resistance islands were discovered in these isolates.
Alarmingly, some of these elements conferred resistance to
carbapenems, antibiotics of last resort for the treatment of
MDR A. baumannii. Ayibieke et al. report carbapenem resistant
Acinetobacter spp. from Ghana. This study is significant since
there is limited data on carbapenem resistant Acinetobacter
from sub-Saharan Africa. The study highlights the importance
of surveillance to better understand the antibiotic resistance
patterns in Acinetobacter from hospital settings. Xanthopoulou
et al. report an A. baumannii isolate from northern Spain that
harbors blaNDM−6. A number of variants of blaNDM−6 have
been reported in various pathogens including A. baumannii.
Critically, the blaNDM−6-carrying isolates reported in this study
came from a patient who traveled to northern Spain following a
medical procedure carried out in Northwest Africa. This leads
to the possibility that blaNDM−6-harboring A. baumannii are
perhaps present beyond northern Spain. While the majority
of studies on Acinetobacter spp. focus on A. baumannii, there
is increasing appreciation of the fact that non-A. baumannii
isolates can be quite significant in clinical settings. Two other
studies in this issue touch upon the growing clinical relevance
of non-A. baumannii isolates. Zhang et al. describe an isolate
of A. pittii isolated from Zhejiang Province in China. This
isolate carried blaOXA−499, blaOXA−826, and blaADC−221 genes,
but is susceptible to imipenem and intermediately susceptible
to meropenem. They were able to isolate an imipenem-resistant
mutant of this isolate under selective pressure. This allowed them
to characterize themutations in blaOXA−499 that confer resistance
to carbapenems, thus showing the potential of A. pittii isolates to
develop carbapenem resistance if they carry a blaOXA−499 gene. In
a different paper, Lee et al. show that overexpression of AdeABC
in clinical isolates of A. nosocomialis is correlated with reduced
susceptibilities to tetracyclines tigecycline, omadacycline, and
eravacycline. This study further highlights the importance of
efflux pumps in reduced susceptibility of bacteria such as A.
nosocomialis to novel antibiotics.
One of the key components that contributes to the success
of A. baumannii as an antibiotic-resistant pathogen is its
complement of outer membrane proteins. In their mini-review,
Uppalapati et al. discuss the latest research on the roles of the
outer membrane proteins OmpA, CarO, and OprD as virulence
factors and in altering membrane permeability in A. baumannii.
They conclude that the evidence to date suggests a major role
for outer membrane proteins in host interaction, infection,
and surviving antibiotic exposure, but that significant gaps in
our knowledge remain. In addition to the outer membrane,
the capsule of A. baumannii is thought to be important for
infection. To investigate this, Loraine et al. examined nearly
200 clinical isolates from three hospitals in Thailand. While
isolates belonging to International Clone (IC) 2 predominated,
a large number of isolates from very diverse STs were identified.
Intriguingly, they found a correlation between the thickness of
capsule being produced and serum resistance but were not able
to determine the reason for the differences in capsule production
between strains. This highlights the potential role of the capsule
in infections with A. baumannii but shows that there is still much
to learn about capsule variability, production, and function.
Understanding the variation between the major clonal lineages
of A. baumannii, and the implications of this, are a major
goal of current research. To this end, Mancilla-Rojano et al.
carried out a study of Acinetobacter isolates collected between
2015 and 2017 from a children’s hospital in Mexico. A high
proportion of the isolates were either MDR (44%) or extensively
drug resistant (11%) and were spread across a diverse range
of 27 different STs. Interestingly, they report nine instances of
more than one ST causing infection in the same patient. Clonal
complex (CC) 79 was the most prevalent (27% of isolates),
which belongs to IC5. It has recently become apparent that the
major epidemic lineages in Latin America are not IC1 and IC2,
but are IC4, IC5, and IC7. There are very few detailed studies
focussing on these strains, and therefore the study byNodari et al.
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looked to address this. They studied carbapenem resistant A.
baumannii isolates from five different Brazilian hospitals, and
found isolates belonged to either IC4 or IC5. All isolates were
MDR including high levels of resistance to polymyxins (72%)
and carried genes for the carbapenemases OXA-23 or OXA-
72. These studies highlight the importance of International
clones other than IC1 and IC2 in Latin America, which is an
area that deserves far more attention. The global prevalence
of carbapenem-resistant clonal lineages has made strategies to
combat these a priority. This was the goal of Chen et al. who show
the value of a long-term study on the impact of a comprehensive
intervention designed to reduce the burden of A. baumannii in
hospitals. The intervention was successful in reducing overall
resistance rates, and the frequency and duration of outbreaks.
However, levels of resistance in the imipenem-resistant isolates
did not decrease, except for tigecycline. The prevalent OXA-
58 carbapenemase-encoding isolates disappeared following the
intervention and were replaced with isolates encoding OXA-23.
While it is encouraging that such intervention strategies can
be effective, their impact upon the population structure of A.
baumannii and associated resistance and virulence phenotypes is
still not clear.
The advent of affordable genomics has greatly increased our
understanding of the factors influencing antibiotic resistance
and virulence in Acinetobacter but significant gaps in our
knowledge still remain. Large-scale genomic studies, in particular
with unbiased isolate selection and including currently under-
represented areas of the word, will reveal the true variation within
species in the genus. By combining genomics with high-quality
clinical and epidemiological data, and laboratory-based assays,
we will achieve a far greater understanding of the link between
genotype and phenotype in these species, shedding light on the
factors that have resulted in Acinetobacter being amongst the
most feared nosocomial pathogens.
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